Public Health

Neonatal abstinence syndrome (NAS) is a condition that affects newborns who receive opioids or addictive substances through the placenta during pregnancy. From 2010-2917, the number of babies born with NAS increased by 82% nationally, for nearly all states and demographic groups. Babies have withdrawal symptoms during their first few days of life. One baby is diagnosed with NAS every 24 minutes in the United States, or more than 59 newborns diagnosed every day (Healthcare Cost and Utilization Project). Drug use and addiction among parents during pregnancy can adversely affect the newborns and have both short-term and long term physical and mental health consequences post-birth.  In partnership with UCSD Department of Pediatrics, Boz Institute utilizes federal data from over 20,000 hospitals visit to assess for potential correlations between newborns NAS diagnosis and socio-economic factors, including the potential biases relative to post-diagnosis medical care and treatments.

*For more about this project, contact flannery@bozinstitute.org

Investigator

Flannery McLamb

Goran Bozinovic

Collaborator

Natalie Laub

Natalie Laub, M.D., Assistant Professor, Department of Pediatrics, UC San Diego